Animal studies are research experiments conducted on non-human animals to understand biology, test new medical treatments, and evaluate the safety of drugs or chemicals before they are used in people. They form a core part of what scientists call “preclinical research,” the stage of investigation that happens before any new therapy is tried in human volunteers. Nearly every major medical advance of the past century, from antibiotics and vaccines to insulin and organ transplants, was developed or tested in animals first.
How Animal Studies Fit Into Medical Research
When scientists develop a hypothesis about what causes a disease or how a new drug might treat it, they need a way to test that idea in a living system before risking human health. Animal models fill that role. Researchers choose a specific species based on how closely its anatomy, physiology, or genetics mirrors the human condition they’re studying. A mouse might be chosen because its immune system can be genetically modified to mimic a human cancer, while a rabbit might be used to study how cholesterol builds up in arteries, since rabbits fed high-cholesterol diets develop the same narrowing that leads to heart attacks in people.
In the drug development pipeline, animal studies typically come after initial lab work in cell cultures and before any human clinical trial. During this preclinical phase, researchers assess several things: whether the drug actually works against the disease (efficacy), how the body absorbs and processes it, and whether it causes toxic effects in organs like the liver, heart, or kidneys. These safety and toxicity studies can last anywhere from a few days to six months, depending on how long patients would eventually take the drug.
Which Animals Are Used
Mice and rats account for roughly 95% of all laboratory animals. Within the European Union, mice alone made up 61% of the 11.5 million animals used in research in 2011, while rats represented about 14%. Their dominance comes down to practical and scientific reasons: they breed quickly, their genomes are well mapped, and researchers can create genetically modified strains that closely replicate specific human diseases. Other species used far less frequently include rabbits, guinea pigs, fish, non-human primates, and dogs, each selected for particular research questions where rodents are not suitable models.
The Three Rs: Ethical Guidelines
Modern animal research is governed by an ethical framework known as the Three Rs, first proposed by scientists William Russell and Rex Burch. The principles are meant to be applied in order of priority.
- Replacement: If a non-animal method (like a cell culture or computer simulation) can answer the research question, it should be used instead of a living animal.
- Reduction: When animals must be used, the experiment should be designed so the fewest possible animals produce reliable results.
- Refinement: Any procedures that could cause pain or distress should be modified to minimize suffering, through better anesthesia, improved housing, or less invasive techniques.
These principles are not just aspirational. In the United States, every institution that conducts animal research with federal funding is required to have an Institutional Animal Care and Use Committee (IACUC). This committee reviews and approves every proposed project involving animals, inspects animal facilities at least twice a year, and has the authority to suspend any study that violates welfare standards. The legal backbone includes the Animal Welfare Act, administered by the U.S. Department of Agriculture, and the Public Health Service Policy on Humane Care and Use of Laboratory Animals.
Major Medical Advances From Animal Research
The list of treatments that depended on animal studies is long. Insulin, which keeps millions of people with diabetes alive, was first extracted and tested in dogs. Organ transplantation techniques were refined in mice and other lab animals before being attempted in humans. Pacemakers, blood pressure medications, antidepressants, and treatments for shock and blood diseases all went through animal testing. The American Medical Association has stated that virtually every advance in medical science in the 20th century was achieved either directly or indirectly through animal experiments. Even the discovery that lithium could stabilize mood, now a standard treatment for bipolar disorder, came from observing its calming effect on guinea pigs.
The Translational Gap
Despite these successes, animal studies have a significant limitation: results in animals frequently do not hold up in people. A 2024 analysis published in PLOS Biology tracked the journey of therapies from animal testing to regulatory approval and found that about 50% of treatments that showed promise in animals advanced to human studies, 40% made it into randomized clinical trials, but only 5% ultimately received regulatory approval. That means 95 out of every 100 therapies that looked effective or safe in animals failed somewhere along the path to becoming an approved treatment.
This gap exists for several reasons. Animal physiology, while similar to human physiology in many ways, is not identical. A drug that is harmless to a mouse liver may be toxic to a human liver. A cancer treatment that shrinks tumors in rats may do nothing in people because the human version of the disease behaves differently at the molecular level. When researchers have directly compared how well mouse models predict outcomes for conditions like Alzheimer’s disease, sepsis, and acute respiratory distress syndrome, the results have been poor.
Alternatives Gaining Ground
The limitations of animal models, combined with ethical concerns, have driven investment in alternative technologies. One of the most promising is the organ-on-a-chip: a small microfluidic device lined with living human cells that mimics how an actual organ functions. These chips can replicate the behavior of lungs, livers, intestines, and other organs under conditions that closely match real human physiology.
Liver chips, for example, have successfully detected drug toxicities that animal testing missed entirely, because rodent and dog livers process certain compounds differently than human livers do. In one case, a lung chip predicted that a specific antibody drug would cause dangerous inflammation in human lungs. When a modified, safer version of the drug was then tested in primates, the animals showed no lung inflammation, confirming what the chip had predicted. An intestine chip modeling radiation injury reproduced the same dose sensitivity seen in human patients, a response that differed from what animal models showed.
These technologies are not yet a complete replacement. The challenge is demonstrating that organ chips are consistently equal to or better than animal models across a wide range of diseases and drug types. But the trajectory is clear: human cell-based systems are increasingly outperforming animal models in predicting how people will actually respond to treatments. The FDA has begun developing roadmaps to reduce reliance on animal testing in preclinical safety studies, signaling a gradual shift in how new therapies will be evaluated in the coming years.
The Ethical Debate
Animal research remains one of the most contested areas in science. Supporters argue that animals, while deserving of good welfare, do not possess the same cognitive capabilities or full autonomy as humans, and therefore their use in research that saves human lives is justified. European and American law reflects this position, permitting animal research as long as welfare standards are met.
Opponents counter that the capacity to feel pain and experience pleasure is what matters morally, not cognitive ability. Since many animals clearly suffer and experience distress, assigning them a lower moral status is a form of prejudice, sometimes called “speciesism,” no different in principle from discrimination based on race or gender. Animal rights advocates argue that no being capable of suffering should be used as a tool for another’s benefit, regardless of the potential scientific gains.
Most modern regulatory frameworks try to occupy a middle ground: allowing animal research when no alternatives exist, but requiring that suffering be minimized and that the potential benefits clearly justify the costs. In practice, this means every proposed experiment must pass ethical review, and researchers must demonstrate that they have considered non-animal alternatives before using a living creature.